Allergan plc today announced that it has seven presentations on the agenda at the American Society of Cataract and Refractive Surgery (ASCRS) Symposium & Congress.
The meeting will be held from May 6-10 at the New
Orleans Ernest N. Morial Convention Center.
Allergan's data is focused on dry eye and glaucoma. The results of two dry eye studies will be presented Monday, May 9. The study on the effectiveness of intranasal lacrimal neurostimulation on tear production was a nonrandomized open-label study. The second, a randomized trial compared intranasal lacrimal neurostimulation with two control applications. The study participants had moderate to severe dry eye.
The glaucoma results include three studies on the Ab Interno Gelatin Stent as a standalone procedure, in combination with Mitomycin-C and with cataract surgery. Two of the studies provide one-year results.
The fourth glaucoma presentation provides information on the development of a collagen stent. The data shows the results of the first 975 eyes treated with this procedure.
The final presentation provides the six-month results of a Phase I/II clinical trial on bimatoprost sustained-release implants. The trial is evaluating the safety and efficiency of the surgical technique in treating glaucoma.
Alerts Sign-up